TRMT13

Model summary

A soluble human RNA-modifying enzyme that binds structured tRNA via tandem zinc-finger modules and uses a SAM-dependent catalytic core to install 2'-O-methyl groups at positions 34 and 4 of tRNA. By coupling high-affinity RNA recognition to precise methyl transfer, it promotes tRNA maturation and stability in both the nucleoplasm and cytosol, coordinating with RNA-processing and translation pathways to fine-tune decoding fidelity.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminus carries IPR021721 (Zinc finger, CCCH-type, TRM13; residues 17–45), followed by IPR022776 (TRM13/UPF0224 family, U11-48K-like CHHC zinc finger domain; residues 56–83). These two RNA-binding zinc-finger modules occur in tandem and create a composite nucleic-acid recognition platform that typically confers high-affinity and specificity toward structured RNAs such as tRNAs. The central-to-C-terminal half is dominated by IPR007871 (Methyltransferase TRM13; residues 165–469), which encodes the catalytic core that binds S-adenosyl-L-methionine and executes methyl transfer chemistry. The entire polypeptide is encompassed by IPR039044 (tRNA:m(4)X modification enzyme Trm13 family; residues 14–469), which functionally unifies the RNA-binding N-terminus and SAM-dependent methyltransferase C-terminus into a single tRNA-modification machine. The ordered layout—RNA-targeting zinc fingers leading into a Trm13 catalytic module—causally establishes a pathway that first captures and positions tRNA, then performs site-specific 2'-O-methyl transfer.

2. 02

   This domain architecture dictates molecular function.

   The Trm13 catalytic core (IPR007871 within IPR039044) provides the chemistry for GO:0062105 RNA 2'-O-methyltransferase activity. The presence of a Trm13 family methyltransferase that modifies both cytidine and guanosine in tRNA supports GO:0016427 tRNA (cytosine) methyltransferase activity and GO:0016423 tRNA (guanine) methyltransferase activity. The tandem CCCH and CHHC zinc fingers (IPR021721 and IPR022776) enforce substrate selection and assembly with auxiliary factors, consistent with GO:0005515 protein binding as an intrinsic property of RNA-processing complexes.

3. 03

   From these molecular activities, the biological process follows directly.

   A SAM-dependent tRNA 2'-O-methyltransferase that modifies positions 34 and 4 in tRNA is executing GO:0030488 tRNA methylation. This modification program stabilizes tRNA structure and tuning of decoding properties, thereby feeding into broader RNA maturation and translation fidelity pathways.

4. 04

   Cellular location is inferred from function and binding modules.

   tRNA transcription and early processing occur in the nucleus, particularly the nucleoplasm, while additional maturation and quality control proceed in the cytosol. The soluble nature of this enzyme and its RNA-centric architecture argue for a non-membranous localization. Thus, the enzyme operates in the GO:0005654 nucleoplasm and GO:0005829 cytosol, matching the dual-compartment life cycle of tRNA modification.

5. 05

   Mechanistically, the N-terminal CCCH and CHHC zinc fingers recruit and orient tRNA, likely recognizing conserved tertiary motifs that present the target nucleotides at positions 34 and 4.

   The C-terminal Trm13 catalytic domain binds SAM and transfers the methyl group to the ribose 2'-hydroxyl, producing m(2'-O)-modified tRNAs that enhance stability and function. I hypothesize that this enzyme forms transient assemblies with RNA-processing and surveillance machinery—such as U11/U12 snRNP-associated factors implied by the U11-48K-like CHHC domain, aminoacyl-tRNA synthetases that chaperone tRNA maturation, and SAM-cycle enzymes that supply the methyl donor—enabling efficient substrate handoff between nucleoplasmic processing and cytosolic finishing steps.